Mixed cryoglobulinemia: New concepts

Lupus

Volumn 9, Issue 2, 2000, Pages 83-91

  Ramos Casals, Manuel ^a   Trejo, Olga ^a   García Carrasco, Mario ^a   Cervera, Ricard ^a   Font, Josep ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Hepatitis C virus; Lymphoma; Mixed cryoglobulinemia; Sjogren's syndrome

Indexed keywords

AUTOANTIBODY; CRYOGLOBULIN; INTERFERON; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; RHEUMATOID FACTOR; RIBAVIRIN;

ANTIGEN ANTIBODY COMPLEX; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; GENETIC HETEROGENEITY; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LYMPHOPROLIFERATIVE DISEASE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULITIS; TEMPERATURE SENSITIVITY;

EID: 0034101881     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300678828127     Document Type: Review

References (103)

1. Wintrobe MM, Buell MV. Hyperproteinemia associated with multiple myeloma. Bull John Hopkins Hosp 1933; 52: 156-165.
2. Lerner AB, Watson CJ. Studies of cryoglobulins. I. Unusual purpura associated with the presence of a high concentration of cryoglobulin (cold precipitable serum globulin). Am J Med Sci 1947; 314: 410-415.
3. Meltzer M, Franklin EC. Cryoglobulinemia: a study of 29 patients. I. IgG and IgM cryoglobulins and factors effecting cryoprecipitability. Am J Med 1966; 40: 828-836.
4. Ramos-Casals M, Cervera R, Trejo O et al. Study of the etiology, clinical manifestations and immunological features of 200 patients with cryoglobulinemia. Arthritis Rheum 1999; 42(Suppl): S212.
5. Brouet JC, Clauvel JP, Danon F et al. Biological and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-788.
6. Musset L, Diemert MC, Taibi F et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38: 798-802.
7. Tissot JD, Schifferli JA, Hochstrasser DF et al. Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide. J Immunol Meth 1994; 173: 63-75.
8. Musset L, Duarte F, Gaillard O, et al. Immunochemical characterization of monoclonal IgG containing mixed cryoglobulins. Clin Immunol Immunopathol 1994; 70: 166-170.
9. Abelmoula M, Spertini F, Shibata T et al. IgG3 is the major source of cryoglobulins in mice. J Immunol 1989; 143: 526-532.
10. Nightingale SD, Pelley RP, Delaney NL et al. Inheritance of mixed cryoglobulinemia. Am J Hum Genet 1981; 33: 735-744.
11. Migliorini P, Bombardieri S, Castellani A, Ferrara GB. HLA antigens in essential mixed cryoglobulinemia. Arthritis Rheum 1981; 24: 932-936.
12. Amoroso A, Berrino M, Canale L et al. Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? J Hepatol 1998; 29: 36-44.
13. Ossi E, Bordin MA, Businaro MA et al. HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. Clin Exp Rheumatol 1995; 13 (Suppl 13): S91-S93.
14. Lenzi M, Frisoni M, Mantovani V et al. Hapolotype HLA-B8-DR3 confers susceptibility to heptatitis C virus-related mixed cryoglobulinemia. Blood 1998; 91: 2062-2066.
15. Levo Y. Nature of cryoglobulinemia. Lancet 1980; i: 285-287.
16. Galli M, Invernizzi F, Chemotti M et al. Cryoglobulins and infectious diseases. La Ricerca Clin Lab 1986; 16: 301-313.
17. Casato M, Taliani G, Pucillo LP et al. Cryoglobulinemia and hepatitis C virus. Lancet 1991; 337: 1047-1048.
18. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992; 117: 573-577.
19. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-570.
20. Gabrielli A, Manzin A, Candela M et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinemia. Clin Exp Immunol 1994; 97: 87-93.
21. Bouffard P, Hayasshi PH, Acevedo R et al. Hepatitis C virus infection is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells. J Infect Dis 1992; 166: 1276-1280.
22. Ferri C, Monti M, La Civita L et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993; 82: 3701-3705.
23. Muñoz-Fernández S, Barnado FJ, Martin-Mola E et al. Evidence of hepatitis C virus antibodies in the cryoprecipitate of patients with mixed cryoglobulinemia. J Rheumatol 1994; 21: 229-233.
24. Cacoub P, Lunel F, Fabiani F et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994; 40: 124-132.
25. Sansonno D, Cornacchiulo V, Iacobelli AR et al. Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995; 21: 305-312.
26. Werner C, Joller-Jemelka HI, Fontana A. Hepatitis C virus and cryoglobulinemia. N Engl J Med 1993; 328: 1122-1123.
27. Galli M, Monti G, Monteverde A et al. Hepatitis C virus and mixed cryoglobulinemia. Lancet 1992; 339: 989.
28. Cacoub P, Lunel F, Musset L et al. Hepatitis C virus and cryoglobulinemia. N Engl J Med 1993; 328: 1121-1122.
29. Levey M, Bjornsson B, Banner B et al. Mixed cryoglobulinemia in chronic hepatitis C infection: a clinicopathologic analysis of 10 cases and review of recent literature. Medicine 1994; 73: 53-67.
30. Crovatto M, Ceselli S, Mazzaro C et al. HCV genotypes and cryoglobulinemia. Clin Exp Rheumatol 1995; 13: S79.
31. Pawlotsky JM, Roudot-Thoraval F, Simmonds P et al. Extrahepatic immunologic manifestations in chronic hepatitis C virus serotypes. Ann Intern Med 1995; 122: 169.
32. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol 1993; 74: 669-676.
33. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
34. Agnello V, Zhang QX, Elfahal M et al. Association of hepatitis C virus with VLDL in type II cryoglobulinemia. 3rd International Meeting on Hepatitis C Virus and Related Viruses. 1995 (abstract).
35. Agnello V, Abel G. Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997; 40: 2007-2015.
36. Thomssen R, Monaxahian M, Bonk S et al. The binding of HCV to lipoproteins. Keystone Symposium on Hepatitis C and Beyond, 1996 (abstract).
37. Agnello V, Abel G, Zhang QX et al. The etiology of mixed cryoglobulinemia: the role of the LDL receptor and apolipoprotein E2. Arthritis Rheum 1997; 39: 5315.
38. Galli M, Invernizzi F, Fiorenza AM et al. Crioglobuline ed immunocomplesi circolanti in epatite A. Acta Medit Patol Infett Trop 1982; 1: 93-103.
39. Levo Y, Gorevic PD, Kassab HJ et al. Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977; 297: 946-947.
40. Realdi G, Alberti A, Rigoli A, Tremolada F. Immune complexes and Australia antigen in cryoglobulinemic sera. Z Immunitats-Forsch 1974; 147: 114-126.
41. Montagnino G. Reappraisal of the clinical expression of mixed cryglobulinemia. Springer Semin Immunopathol 1988; 10: 1-10.
42. Popp JW Jr, Dienstag JL, Wands JR, Block KJ. Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 1980; 92: 379-383.
43. Galli M, Monti G, Invernizzi F et al. Hepatitis B virus-related markers in secondary and in essential mixed cryoglobulinemias: a multicentric study of 596 cases. Ann Ital Med Int 1992; 7: 209-214.
44. Misiani R, Mantero G, Bellavita P et al. GB virus C infection in patients with type II mixed cryoglobulinemia. Ann Intern Med 1997; 127: 891-894.
45. Cassan M, Lilli D, Rivanera D et al. HCV/HGV coinfection and cryoglobulinemia. J Hepatol 1998; 28: 355-357.
46. Cacoub P, Frangeul L, Musset L. Hepatitis G and mixed cryoglobulinemia. Am Intern Med 1997; 126: 1002.
47. Utsinger PD. Immunologic studies of arthritis associated with adenoviral infection. Arthritis Rheum 1977; 3: 188 (abstract).
48. Dimitrakopoulos A, Kordossis T, Hatzakis A, Moutsopoulos HM. Mixed cryoglobulinemia in HIV-1 infection: the role of HIV-1. Ann Intern Med 1999; 130: 226-230.
49. Mellors JW, Kingsley LA, Rinaldo CR Jr et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122: 573-579.
50. Bett DCG. Gougerot's maladie trysimptomatique avec cryoglobulinemia. Proc R Soc Med 1958; 51: 325.
51. Ramos-Casals M, Cervera R, Yagüe J et al. Cryoglobulinemia in primary Sjögren's syndrome: prevalence and clinical characteristics in a series of 115 patients. Semin Arthritis Rheum 1998; 28: 200-205.
52. Tzioufas AG, Manoussakis MN, Costello R et al. Cryoglobulinemia in autoimmune rheumatic diseases: evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome. Arthritis Rheum 1986; 29: 1098-1103.
53. Vitali C, Tavioni A, Bombardieri S. La sindrome di Sjögren primitiva. Reumatismo 1987; 39: 64-69.
54. Tzíoufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996; 39: 767-772.
55. Invernizzi F, Galli M, Serino G et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification and long-term follow-up. Acta Haematol 1983; 70: 73-82.
56. Moutsopoulos H, Tzioufas A, Bai M et al. Association of serum IgMk monoclonicity in patients with an increased proportion of k positive plasma cells infiltrating the labial minor salivary glands. Ann Intern Med 1990; 113: 929-931.
57. García-Carrasco M, Ramos-Casals M, Cervera R et al. Hepatitis C virus infection in "primary" Sjögren's syndrome: prevalence and clinical sig-nificance in a series of 90 patients. Ann Rheum Dis 1997; 56: 173-175.
58. Garcia-Bragado F, Vilardell M, Fonollosa V et al. Crioglobulinas en enfermedades sistémicas y reumáticas. Estudio en 70 casos. Med Clin (Barcelona) 1980; 74: 209-213.
59. Toblli JE, Trigo M, Mendoza G et al. Manifestaciones hematológicas en el lupus eritematoso sistémico. Experiencia recogida en 150 casos. Rev Clin Esp 1983; 169: 257-260.
60. Ortega G, Molina M, Bermudo J et al. Significado de las crioglobulinas en el curso clínico del lupus eritematoso sistémico. Med Clin 1984; 83: 358-360.
61. Agnello V, Koffler D, Eisenberg et al. C1q precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 1971; 134: 228.
62. Winfield JB, Koffler D, Kunkel HG. Specific concentration of polynucleotide immune complexes in the cryoprecipitates of patients with systemic lupus erythematosus. J Clin Invest 1975; 56: 563.
63. Weisman N, Zvaifler NJ. Cryoglobulinemia in Felty's syndrome. Arthritis Rheum 1976; 19: 103.
64. Weisman N, Zvaifler NJ. Cryoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis. J Clin Invest 1975; 56: 725.
65. Barnett E, Bluestone R, Cracchiolo A et al. Cryoglobulinemia and disease. UCLA conference. Ann Intern Med 1970; 73: 95-107.
66. Lambie PB, Quisimorio FP. Interstitial lung disease and cryoglobulinemia in polymiositis. J Rheumatol 1991; 18: 468-469.
67. Arana RM, Roux ME, García Morteo O et al. Crioglobulinemia. Medicina (Buenos Aires) 1971; 31: 323.
68. Carson CW, Conn DL, Czaja AJ. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20: 304-309.
69. Zignego AL, Bréchot C. Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 1999; 31: 369-376.
70. Gorevic PD, Frangione B. Mixed cryoglobulinemia cross-reactive idiotypes: implications for the relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991; 28: 79-94.
71. Monteverde A, Rivano MT, Allegra GC et al. Essential mixed cryoglobulinemia, type II: a manifestation of low-grade malignant lymphoma? Clinical morphological study of 12 cases with special reference to immunohistochemical findings. Acta Haematol 1988; 79: 20-25.
72. Pozzato G, Mazzaro C, Crovatto M et al. Low-grade malignant lymphoma, hepatitis C virus infection and MC. Blond 1994; 84: 3047-3053.
73. Ferri C, Monti M, La Civita L et al. Hepatitis C virus infection in non-Hodgkin's B cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994; 24: 781-784.
74. La Civita L, Zignego AL, Monti M et al. Mixed cryoglobulinemia as a possible preneoplastic disorder. Arthritis Rheum 1995; 38: 1859-1860.
75. Zignego AL, Decarli M, Monti M et al. Hepatitis C virus infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 1995; 47: 58.
76. Sansonno D, De Vita S, Cornacchiulo V et al. Detection and distribution of hepatitis C virus-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoprofileration. Blood 1996; 88: 4296.
77. Silvestri F, Barillari G, Fanin R et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997; 82: 314-317.
78. Silvestri F, Pipan C, Barillari G et al. Prevalence of hepatitis C infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-4301.
79. Ferri C, Caracciolo F, Zignego AL et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994; 88: 392-394.
80. Ferri C, La Civita L, Longombardo G, Zignego AL, Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998; 7: 275-279.
81. Ferri C, La Civita L, Zignego AL et al. Viruses and cancers: possible role of hepatitis C virus. Eur J Clin Inves 1997; 27: 711-718.
82. Mishiro S, Takeda K, Hoshi Y et al. An autoantibody crossreactive to hepatitis C virus core and a host nuclear antigen. Autoimmunity 1991; 10: 269-273.
83. Ellis M, Rathaus M, Amiel A et al. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia. Eur J Clin Invest 1995; 25: 833-837.
84. Monteverde A, Sabattini E, Poggi S et al. Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation. Leuk Lymphoma 1995; 20: 119-124.
85. Monteverde A, Ballare M, Pileri S. Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia. Springer Semin Immunopathol 1997; 19: 99-110.
86. Jaeger U, Karth GD, Knapp S et al. Molecular mechanism of the t(14;18). A model for lymphoid-specific chromosomal translocations. Leuk Lymphoma 1994; 14: 197-202.
87. Ueda N, Shah SV. Apoptosis. J Lab Clin Med 1994; 124: 169-177.
88. McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349: 254-256.
89. Ramos-Casals M, García-Carrasco M, Font J, Cervera R. Sjögren's syndrome and lymphoproliferative disease. In: Shoenfeld Y, Gershwin E (eds) Cancer and Autoimmunity. Elsevier: Amsterdam, 2000 (in press).
90. Ramos-Casals M, García-Carrasco M, Cervera R, Font J. Sjögren's syndrome and hepatitis C virus. Clin Rheumatol 1999; 18: 93-100.
91. Cresta P, Musset L, Cacoub L et al. Response to interferon α treatment and disappearance of cryoglobulinemia in patients infected by hepatitis C virus.. Gut 1999; 45: 122-128.
92. Misiani R, Bellavita P, Fenili D et al. Interferon alfa 2a therapy in crioglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-756.
93. Casato M, Agnello V, Pucillo LP et al. Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection. Blood 1997; 90: 3865-3873.
94. Ferri C, Marzo E, Longombardo G et al. Interferon α in mixed cryoglobulinemia patients: a randomised, crossover-controlled trial. Blood 1993; 81: 1132-1136.
95. Adinolfi LE, Utili R, Zampino R et al. Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinemia. Eur J Gastroenterol Hepatol 1997; 11: 1067-1072.
96. Durand JM, Cacoub P, Lunel-Fabiani F et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol 1998; 25: 1115-1117.
97. Ning Q, Brown D, Parodo J et al. Ribavirin inhibits viral induced macrophage production of TNF, IL-1 and procoagulant activity and preserves Th1 cytokine production, but inhibits Th2 cytokine response. Hepatology 1996; 24: 355.
98. Reichard O, Norkrans G, Fryden A et al. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet 1998; 351: 83-87.
99. Poynard T, Marcellin P, Lee SS et al. Randomised trial of interferon α 2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α 2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-1432.
100. Davis GL, Esteban-Mur R, Rustgi V et al. Interferon alpha 2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339: 1493-1499.
101. Donada C, Crucitti A, Donadon V et al. Interferon α and ribavirin therapy in patients with chronic hepatitis C and mixed cryoglobulinemia. 1998; 92: 2983-2984.
102. Andreone P, Cursano C, Gramenzi A et al. A double-blind, placebo-controlled, pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C. Liver 1996; 16: 207-210.
103. Sherman KE et al. Combination therapy with thymosin alpha 1 and interferon for the treatment of chronic hepatitis C virus infection: a randomized, placebo-controlled double blind trial. Hepatology 1998; 27: 1128-1135.